key publications

 
 
image006.jpg

Featured publications

  • Eijkelkamp N, Steen-Louws C, Hartgring SA, Willemen HL, Prado J, Lafeber FP, Heijnen CJ, Hack CE, van Roon JA, Kavelaars A (2016) IL4 –10 fusion protein is a novel drug to treat persistent inflammatory pain. J Neurosci 36: 7353–7363.

  • van Vulpen LFD, Popov-Celeketic J, van Meegeren MER et al. (2017) A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo. J Thromb Haemost; 15: 1788–98.

  • Steen‐Louws C, Popov‐Celeketic J, Mastbergen SC et al. (2018) IL4‐10 fusion protein has chondroprotective, anti‐inflammatory and potentially analgesic effects in the treatment of osteoarthritis. Osteoarthritis Cartilage 26: 1127‐ 35.

  • Prado J, Popov-Celeketic J, Steen-Louws C et al. (2018) Development of Recombinant Proteins to Treat Chronic Pain. J Vis Exp. (134), e57071.

  • Steen-Louws C, Hartgring SAY, Popov-Celeketic J et al. (2019) IL4-10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10, Clin Exp Immunol. 195(1): 1-9